<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND OBJECTIVES: Chromosome band 11q23 is frequently deleted in various types of <z:hpo ids='HP_0002664'>neoplasm</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The region represented by yeast artificial chromosome (YAC) clone 755b11 at 11q23 has been shown to be the minimal common region of deletion in mantle cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCL</z:e>) and B-cell <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo> (B-CLL) </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of the study was to determine the frequencies of 11q23 deletion in different <z:hpo ids='HP_0002665'>lymphoma</z:hpo> subtypes </plain></SENT>
<SENT sid="3" pm="."><plain>DESIGN AND METHODS: We performed fluorescence in situ hybridization (FISH) analysis with YAC755b11 on either peripheral blood or lymph node biopsy (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e>) specimens of patients diagnosed as having <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCL</z:e> (47), CLL/small lymphocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SLL</z:e>) (62), diffuse large cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (DLCL) (17), follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (FL) (9), and <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>) (11) </plain></SENT>
<SENT sid="4" pm="."><plain>Fifteen cases of reactive or <z:mpath ids='MPATH_458'>normal</z:mpath> lymph node biopsies were studied as controls </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Forty of the 161 (25%) samples exhibited deletions in the region represented by YAC755b11 </plain></SENT>
<SENT sid="6" pm="."><plain>The 11q23 deletion was found only in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCL</z:e> (23, 49%), CLL / <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SLL</z:e> (13, 21%) and DLCL (4, 24%) </plain></SENT>
<SENT sid="7" pm="."><plain>Three cases were classified as <z:e sem="disease" ids="C0349631" disease_type="Neoplastic Process" abbrv="">Richter's syndrome</z:e> and they <z:hpo ids='HP_0000001'>all</z:hpo> exhibited the deletion at 11q23 </plain></SENT>
<SENT sid="8" pm="."><plain>The deletion frequencies in the blood specimens of typical CLL (30%) and lymph node specimens of <z:e sem="disease" ids="C1302547" disease_type="Neoplastic Process" abbrv="">CLL/SLL</z:e> (13%) were remarkably different </plain></SENT>
<SENT sid="9" pm="."><plain>INTERPRETATION AND CONCLUSIONS: Our study demonstrated that the 11q23 deletion is not common in <z:hpo ids='HP_0002665'>lymphomas</z:hpo> other than <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCL</z:e>, CLL and DLCL </plain></SENT>
<SENT sid="10" pm="."><plain>It also showed the possible correlation of the 11q23 deletion with the transformation of localized <z:hpo ids='HP_0002665'>lymphoma</z:hpo> to CLL, and with the development of <z:e sem="disease" ids="C0349631" disease_type="Neoplastic Process" abbrv="">Richter's syndrome</z:e> </plain></SENT>
</text></document>